Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of Nifurtimox in the Treatment of Chagas Disease: a Long-Term Retrospective Cohort Study in Children and Adults
Nicolás Falk, Ariel Berenstein, Guillermo Moscatelli, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 5
Open Access | Times Cited: 19

Showing 19 citing articles:

Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com Cardiomiopatia da Doença de Chagas – 2023
José Antônio Marin‐Neto, Anis Rassi, Gláucia Maria Moraes de Oliveira, et al.
Arquivos Brasileiros de Cardiologia (2023) Vol. 120, Iss. 6
Open Access | Times Cited: 36
Tackling the Challenges of human Chagas Disease: a Comprehensive Review of Treatment Strategies in the Chronic Phase and Emerging Therapeutic Approaches
Laís G. Ramos, Kátia R. de Souza, Policarpo Ademar Sales, et al.
Acta Tropica (2024) Vol. 256, pp. 107264-107264
Closed Access | Times Cited: 8
In vitro and in vivo leishmanicidal and trypanocidal activities of isoflavans from Tabebuia chrysantha (Jacq.) G. Nicholson timber by-products
Edwin Correa, Sara M. Robledo, Fernando Echeverri, et al.
Experimental Parasitology (2025), pp. 108899-108899
Open Access
Redefining the treatment of Chagas disease: a review of recent clinical and pharmacological data for a novel formulation of nifurtimox
Jaime Altcheh, Ulrike Grossmann, Heino Staß, et al.
PLoS neglected tropical diseases (2025) Vol. 19, Iss. 2, pp. e0012849-e0012849
Open Access
Structure-Based Identification of Non-covalent Prolyl Oligopeptidase 80 Inhibitors Targeting Trypanosoma cruzi Cell Entry
Vinícius Alexandre Fiaia Costa, Flávia Nader Motta, Alexandra Maria dos Santos Carvalho, et al.
Journal of Chemical Information and Modeling (2025)
Open Access
Efficacy and Safety of Nifurtimox in Pediatric Patients with Chagas Disease: Results at 4-Year Follow-Up in a Prospective, Historically Controlled Study (CHICO SECURE)
Jaime Altcheh, Víctor Parra Sierra, Teresa Ramirez, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 4
Open Access | Times Cited: 10
Efficacy of short-course treatment for prevention of congenital transmission of Chagas disease: A retrospective cohort study
Guillermo Moscatelli, Samanta Moroni, Juan Carlos Ramı́rez, et al.
PLoS neglected tropical diseases (2024) Vol. 18, Iss. 1, pp. e0011895-e0011895
Open Access | Times Cited: 2
Evaluation of the Anti-Histoplasma capsulatum Activity of Indole and Nitrofuran Derivatives and Their Pharmacological Safety in Three-Dimensional Cell Cultures
Carolina Orlando Vaso, Níura Madalena Bila, Fabiana Pandolfi, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 1043-1043
Open Access | Times Cited: 11
Genetic Characterization of Trypanosoma cruzi I Populations from an Oral Chagas Disease Outbreak in Venezuela: Natural Resistance to Nitroheterocyclic Drugs
Arturo Muñoz-Calderón, José Luis Ramı́rez, Zoraida Díaz‐Bello, et al.
ACS Infectious Diseases (2023) Vol. 9, Iss. 3, pp. 582-592
Closed Access | Times Cited: 5
Andrographolide: A Diterpenoid from Cymbopogon schoenanthus Identified as a New Hit Compound against Trypanosoma cruzi Using Machine Learning and Experimental Approaches
Henrique Barbosa, Gabriel Zarzana Espinoza, Maiara Amaral, et al.
Journal of Chemical Information and Modeling (2023) Vol. 64, Iss. 7, pp. 2565-2576
Closed Access | Times Cited: 5
Exploring the Potential of Natural Products as Antiparasitic Agents for Neglected Tropical Diseases
Dayanna Orosco, Arturo René Mendoza Salgado, Carlos M. Meléndez
Current Topics in Medicinal Chemistry (2023) Vol. 24, Iss. 2, pp. 89-108
Closed Access | Times Cited: 4
Listen to what the animals say: a systematic review and meta-analysis of sterol 14-demethylase inhibitor efficacy for in vivo models of Trypanosoma cruzi infection
Margarita Bisio, Laura Smeldy Jurado Medina, Facundo García‐Bournissen, et al.
Parasitology Research (2024) Vol. 123, Iss. 6
Closed Access | Times Cited: 1
Avoiding Clinical Trial Failures in Neglected Tropical Diseases: The Example of Chagas Disease
Rick L. Tarleton
Clinical Infectious Diseases (2022) Vol. 76, Iss. 8, pp. 1516-1520
Closed Access | Times Cited: 6
Guías Latinoamericanas de Infecciones Congénitas y Perinatales de la Sociedad Latinoamericana de Infectología Pediátrica (SLIPE). Parte I
Liliana Noemí Vázquez, Marisa Márcia Mussi‐Pinhata, Lola Vozza, et al.
Revista chilena de infectología (2024) Vol. 41, Iss. 1, pp. 60-105
Open Access
Ten years follow-up of the largest oral Chagas disease outbreak: Cardiological prospective cohort study
Raiza Ruiz‐Guevara, Belkisyolé Alarcón de Noya, Iván Mendoza, et al.
PLoS neglected tropical diseases (2023) Vol. 17, Iss. 10, pp. e0011643-e0011643
Open Access | Times Cited: 1
Nifurtimox

Reactions Weekly (2023) Vol. 1940, Iss. 1, pp. 340-340
Closed Access
Introduction
Rahime Şimşek, Aqsa Farooqui, Salahuddin Khan, et al.
(2023), pp. 1-46
Closed Access
Green synthetic strategies and pharmaceutical applications of thiazine and its derivatives: An updated review
Yashumati Ratan, Aishwarya Rajput, Ashutosh Pareek, et al.
Current Pharmaceutical Biotechnology (2023) Vol. 25, Iss. 9, pp. 1142-1166
Closed Access
Chagas Disease: An Overview of Current Understanding and Future Perspectives
Chanda Naseem, Warda Irfan, Ammal Ali, et al.
International Journal of Agriculture and Biosciences (2023), Iss. Zoonosis Volume 2, pp. 113-125
Open Access
Page 1

Scroll to top